N-{[4-(difluoromethyl)-1,2,3-thiadiazol-5-yl]methyl}ethene-1-sulfonamide
Structure Info
- Chemspace ID
- CSSB20526668115 (In-Stock Building Blocks)
- IUPAC Name
- N-{[4-(difluoromethyl)-1,2,3-thiadiazol-5-yl]methyl}ethene-1-sulfonamide
- Mol formula
- C6H7F2N3O2S2
- Mol weight
- 255 Da
- Catalog Number(s)
- BBLS20526668115, BBV-1378087377, EN300-54662786, bbls20526668115
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 0.41
- Heavy atoms count
- 15
- Rotatable bond count
- 4
- Number of rings
- 1
- Carbon bond saturation, Fsp3
- 0.333
- Polar surface area (Å)
- 72
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 1
![Chemical structure of N-{[4-(difluoromethyl)-1,2,3-thiadiazol-5-yl]methyl}ethene-1-sulfonamide (C6H7F2N3O2S2) - CSSB20526668115](/st/structure/200/91a55d13f87d8b6e4300624130f0c987/FC%2528F%2529C1%253DC%2528CNS%2528%253DO%2529%2528%253DO%2529C%253DC%2529SN%253DN1.png "C6H7F2N3O2S2")
- Zoom the structure
- CSSB20526668115
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 912.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 955.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 999.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 1,042.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 1,086.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 2,127.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 3,147.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 4,667.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of N-[(4-cyclopropyl-1,2,3-thiadiazol-5-yl)methyl]ethene-1-sulfonamide - CSSB03548232987](/st/structure/200/c1f5cba729d490a8436b287551873024/C%253DCS%2528%253DO%2529%2528%253DO%2529NCC1%253DC%2528N%253DNS1%2529C1CC1.png)
![Chemical structure of N-[(4-cyclobutyl-1,2,3-thiadiazol-5-yl)methyl]ethene-1-sulfonamide - CSSB03443467184](/st/structure/200/4a057cdf14265ff62139cd2da0e9b15b/C%253DCS%2528%253DO%2529%2528%253DO%2529NCC1%253DC%2528N%253DNS1%2529C1CCC1.png)
![Chemical structure of N-{[4-(difluoromethyl)-5-methyl-1,3-thiazol-2-yl]methyl}ethene-1-sulfonamide - CSSB21332166248](/st/structure/200/9529c0ef06cb0e3b734f27cb26049dd6/CC1%253DC%2528N%253DC%2528CNS%2528%253DO%2529%2528%253DO%2529C%253DC%2529S1%2529C%2528F%2529F.png)
![Chemical structure of N-[(4-methyl-1,2,3-thiadiazol-5-yl)methyl]ethene-1-sulfonamide - CSSB00154416487](/st/structure/200/983c621086dad130d30c2d4d1f08ae66/CC1%253DC%2528CNS%2528%253DO%2529%2528%253DO%2529C%253DC%2529SN%253DN1.png)
![Chemical structure of N-{[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]methyl}ethene-1-sulfonamide - CSSB21332053741](/st/structure/200/adb9d0e87a5e3250d701977db2f41a13/FC%2528F%2529C1%253DNN%253DC%2528CNS%2528%253DO%2529%2528%253DO%2529C%253DC%2529S1.png)
![Chemical structure of N-{[4-(difluoromethyl)-1,2,3-thiadiazol-5-yl]methyl}prop-2-enamide - CSSB20526684394](/st/structure/200/485ca031102326ac34860a7f68e1554b/FC%2528F%2529C1%253DC%2528CNC%2528%253DO%2529C%253DC%2529SN%253DN1.png)
![Chemical structure of N-{[3-(difluoromethyl)-1,2-thiazol-4-yl]methyl}ethene-1-sulfonamide - CSSB07104298607](/st/structure/200/c2ab06d87d0b4ca45143589c29c91cd2/FC%2528F%2529c1nscc1CNS%2528%253DO%2529%2528%253DO%2529C%253DC.png)
